UK markets open in 1 hour 7 minutes
NIKKEI 225
37,188.75 -890.95 (-2.34%) HANG SENG
16,150.88 -234.99 (-1.43%) CRUDE OIL
84.45 +1.72 (+2.08%) GOLD FUTURES
2,397.30 -0.70 (-0.03%) DOW
37,775.38 +22.07 (+0.06%) Bitcoin GBP
50,186.80 +730.28 (+1.48%)
PDS Biotechnology Corporation (PDSB)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 106.37M |
| Enterprise value | 73.66M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 4.07 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -1.84 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.72 |
| 52-week change 3 | -55.99% |
| S&P500 52-week change 3 | 21.23% |
| 52-week high 3 | 10.2700 |
| 52-week low 3 | 2.6800 |
| 50-day moving average 3 | 4.6870 |
| 200-day moving average 3 | 5.0645 |
Share statistics
| Avg vol (3-month) 3 | 927.8k |
| Avg vol (10-day) 3 | 793.62k |
| Shares outstanding 5 | 36.68M |
| Implied shares outstanding 6 | 36.68M |
| Float 8 | 35.41M |
| % held by insiders 1 | 3.67% |
| % held by institutions 1 | 22.95% |
| Shares short (28 Mar 2024) 4 | 6.15M |
| Short ratio (28 Mar 2024) 4 | 4.76 |
| Short % of float (28 Mar 2024) 4 | 17.56% |
| Short % of shares outstanding (28 Mar 2024) 4 | 16.77% |
| Shares short (prior month 29 Feb 2024) 4 | 5.03M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 18 Mar 2019 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:20 |
| Last split date 3 | 18 Mar 2019 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -39.45% |
| Return on equity (ttm) | -122.46% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -42.99M |
| Net income avi to common (ttm) | -42.94M |
| Diluted EPS (ttm) | -1.3900 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 56.56M |
| Total cash per share (mrq) | 1.54 |
| Total debt (mrq) | 23.85M |
| Total debt/equity (mrq) | 91.28% |
| Current ratio (mrq) | 4.33 |
| Book value per share (mrq) | 0.79 |
Cash flow statement
| Operating cash flow (ttm) | -33.64M |
| Levered free cash flow (ttm) | -21.17M |
© 2024 Yahoo. All rights reserved.